Moores UC San Diego Cancer Center
La Jolla, California 92093-0698
1 studies enrolling now · 22 studies all time
What they study most
AML With Mutated NPM1, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, in Relapse, Advanced Breast Cancer, Advanced Cancers, Advanced Malignant Solid Tumors, Advanced Non Small Cell Lung Cancer, Advanced Solid Tumors, B-cell Non-Hodgkins Lymphoma, Brain Tumor, Recurrent
Studies at this site
- A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML — Recruiting now
- Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma — Completed
- Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
- Gynecologic Brachytherapy-Specific Educational Video — Completed
- Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer — Completed
- Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies — Completed
- A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer — Completed
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA — Completed
- Phase 2 Study of Duvelisib in Previously Treated Patients With Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma — Withdrawn before enrolling
- Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer — Stopped early
- Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers — Completed
- Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma — Completed
- Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC — Completed
- ANG1005 in Patients With Recurrent High-Grade Glioma — Completed
- Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB — Withdrawn before enrolling
- A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer — Stopped early
- A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer — Completed
- Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers — Completed
- An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer — Stopped early
- Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery — Completed
- An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
- Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer — Completed